Precision prescribing data, and precision customer data. These are the two holy grails pharma needs.
When put together, they form one giant grail that can really give industry the gift of – if not eternal life – then the best possible truth about the healthcare market, its challenges and its opportunities.
Let’s get on with this metaphor.
Grail one is robust patient-level drugs numbers, by disease, at account level – that’s your granular patient share, by disease, by account.
Grail two is exact HCP targeting – knowing the precise treaters of these patients, so you can access and engage with them.
Check out the rest of the feature here
